|
End-of-day quote
Korea S.E.
23/09/2026
|
5-day change | 1st Jan Change | ||
| 4,320.00 KRW | -3.14% |
|
-4.95% | -20.81% |
| 05-19 | Gl Pharm Tech Corp - Announces Reverse Stock Split | RE |
| 03/05/24 | An undisclosed buyer acquired 3.23% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund for KRW 3.97 billion. | CI |
| Market Cap | 67B 49.06M 43.06M 40.47M 37M 69.15M 4.7B 69.66M 486M 188M 2.4B 184M 180M 7.77B | P/E 2024 |
-31x | P/E 2025 | 6,737x |
|---|---|---|---|---|---|
| Enterprise Value | 82.7B 60.55M 53.14M 49.95M 45.67M 85.35M 5.8B 85.98M 600M 233M 2.96B 227M 222M 9.59B | EV / Sales 2024 |
3.28x | EV / Sales 2025 | 2.84x |
| Free-Float |
70.23% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.14% | ||
| 1 week | -4.95% | ||
| Current month | -10.19% | ||
| 1 month | +2.73% | ||
| 3 months | -0.80% | ||
| 6 months | -16.92% | ||
| Current year | -20.81% |
| 1 week | 4,300 |  | 4,580 |
| 1 month | 4,160 | | 5,950 |
| Current year | 3,760 | | 5,975 |
| 1 year | 3,760 | | 6,650 |
| 3 years | 3,760 | | 9,220 |
| 5 years | 3,275 | | 9,220 |
| 10 years | 1,950 | | 42,250 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong-Il Kim
CEO | Chief Executive Officer | 47 | 19/03/2024 |
Seong-Pil Jin
CEO | Chief Executive Officer | 57 | 19/03/2024 |
Young-Pil Kim
DFI | Director of Finance/CFO | 47 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Seong-Pil Jin
BRD | Director/Board Member | 57 | 19/03/2024 |
Yong-Il Kim
BRD | Director/Board Member | 47 | 19/03/2024 |
Han-Gon Choi
BRD | Director/Board Member | 65 | 28/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/13/24 A | Ideal Private Equity Co., Ltd.
| Sell | Company | 4,886,450 | 7.7704% | |
| 3/13/24 A | Ideal Private Equity Co., Ltd.
| Sell | Company | 9,242 | 0.0147% | |
| 3/12/24 A | Buy | Company | 13,813,813 | 21.9666% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.14% | -4.95% | -27.39% | -13.60% | 49.06M | |
| -1.64% | +1.16% | +54.09% | +109.07% | 1,026B | |
| -0.01% | +0.71% | +52.44% | +67.71% | 649B | |
| -0.05% | +0.98% | +19.08% | +73.55% | 468B | |
| 0.00% | +0.33% | +39.44% | +45.22% | 352B | |
| +0.98% | +2.33% | +21.35% | +28.35% | 271B | |
| -0.58% | -0.66% | +10.13% | +10.29% | 256B | |
| -1.01% | +7.90% | +41.59% | +51.70% | 220B | |
| -0.85% | +2.50% | +32.32% | +101.80% | 188B | |
| -1.05% | -10.56% | -32.75% | -60.79% | 170B | |
| Average | -0.25% | +0.65% | +21.03% | +41.33% | 359.92B | |
| Weighted average by Cap. | +0.61% | +1.26% | +36.21% | +65.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 26.05B 19.07M 16.74M 15.73M 14.39M 26.88M 1.83B 27.08M 189M 73.27M 931M 71.62M 70.05M 3.02B | 35.27B 25.82M 22.66M 21.3M 19.48M 36.4M 2.47B 36.67M 256M 99.2M 1.26B 96.97M 94.84M 4.09B |
| Net income | -2.34B -1.71M -1.5M -1.41M -1.29M -2.41M -164M -2.43M -16.96M -6.57M -83.58M -6.43M -6.29M -271M | 12.49M 9.14K 8.03K 7.54K 6.9K 12.89K 876K 12.98K 90.61K 35.13K 447K 34.34K 33.59K 1.45M |
| Net Debt | 10.39B 7.61M 6.68M 6.28M 5.74M 10.73M 729M 10.8M 75.4M 29.23M 372M 28.57M 27.95M 1.2B | 15.7B 11.49M 10.09M 9.48M 8.67M 16.2M 1.1B 16.32M 114M 44.15M 561M 43.16M 42.21M 1.82B |
Employees
33
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/09/26 | ₩4,320.00 | -3.14% | 46,113 |
| 22/09/26 | ₩4,460.00 | 0.00% | 35,705 |
| 21/09/26 | ₩4,460.00 | -2.19% | 32,341 |
| 18/09/26 | ₩4,560.00 | +0.44% | 18,938 |
| 17/09/26 | ₩4,540.00 | -0.11% | 32,069 |
- Stock Market
- Stocks
- A204840 Stock
Select your edition
All financial news and data tailored to specific country editions
